Sumgen Biotech Granted with First National Invention Patent
The Company was granted the invention patent for A Monoclonal Antibody that Specifically Binds to AXL by the China National Intellectual Property Administration (CNIPA) on Sep. 25, 2018. This is the first national invention patent granted to the Company.
Sumgen Biotech is specialized in the R&D of innovative therapeutic antibody drugs and places great emphasis on the development of intellectual property strategies, including the application of a series of core patents around the company's key projects. At present, the company has applied for 6 national invention patents and 1 PCT patent. Sumgen Biotech's strategic layout of patents will provide strong scientific and technological support for the company's future development.
Certificate of Invention Patent
|
Invention name: |
A Monoclonal Antibody that Specifically Binds to AXL |
|
|
Invented by: |
Gao Chan |
|
|
Patent No.: |
ZL 20171 1261529.9 |
|
|
Patent application date: |
Dec. 4, 2017 |
|
|
Patentee: |
Hangzhou Sumgen Biotech Co., Ltd. |
|
|
Address: |
Rm.005, F3, Huannuo Building, No. 1568, Nanhuan Road, Changhe Street, Binjiang District, Hangzhou, Zhejiang Province, 310002 |
|
|
Date of authorized announcement: |
Sep. 25, 2018 |
Authorized announcement No.: CN 107759691 B |
The present invention has been reviewed by our bureau according to the Patent Law of People's Republic of China. The patentee is authorized with patent rights, granted with this certificate, and registered on the Patent Register. The patent rights are valid from the date of authorized announcement.
The duration of the patent rights is 20 years, starting from the day of application. The patentee shall pay the annual fee according to the Patent Law and its detailed rules for implementation. The annual fee for the patent rights shall be paid before December 4th of every year. If the annual fee is not paid as required, the patent rights will expire on December 4th of that year.
The legal status upon patent right registration is documented on the patent license. The transfer, pledge, nullity, termination and recovery of the patent rights as well as the name, nationality and address change of the patentee are documented on the patent license.
|
Commissioner Shen Changyu |
|
|
Copyright Rm. 301, F3, Building C, Block 2, No. 688, Bin'an Road, Changhe Zhejiang ICP Filing No. 18039044
